For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Study of Viruses in Patients with Neurological Disorders and Infections

Clinical Trial Title: 
Study on the detection of viruses in patients with neurological disorders and infections.
Clinical Trial Protocol ID: 
16042001
Clinical Trial Investigator Name: 
Igor J. Koralnik, MD
Clinical Trial Protocol Description: 

The purpose of this study is to determine which viruses are present in the cerebral spinal fluid (CSF) of patients with various neurological disorders and infections. CSF will be collected as leftovers from a lumbar puncture. A blood sample of 30 mL (about 2 tablespoons) will also be taken to identify which viruses were unable to cross the blood-brain barrier.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a neurological disorder or suspected CNS infection.

You will be excluded from the study if any of the following criteria apply to you:

  • Are pregnant.
  • Are cognitively impaired.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Neurological Disorders
Contact Phone: 
(312) 563-7317 or (312) 563-7304
Contact Name: 
Dom Tucker or Zack Orban